Kimberlee Cobleigh Drapkin
Independent DirectorMs. Kimberlee Cobleigh Drapkin, also known as Kim, CPA, also known as Kim, is an Independent Director of Climb Bio, Inc. from March 2025. Ms. Drapkin has B.S. in Accounting from Babson College. She is a seasoned financial leader with over 30 years of experience guiding private and publicly traded biotechnology and pharmaceutical companies through strategic growth, financial planning, capital raises and transformative transactions. She serves as Board Chair of Lucy Therapeutics, Inc. since October 2024 and as an Independent Director at Lenz Therapeutics, Inc. since July 2023. Ms. Drapkin was an Independent Director of Graphite Bio, Inc. from August 3, 2023 to March 2024 and has been serving as its President, Chief Executive Officer and Principal Executive, Financial & Accounting Officer since August 21, 2023. She also serves as Chief Operating Officer at Graphite Bio, Inc. Prior to her current roles, Ms. Drapkin served as President of Jounce Therapeutics, Inc. since April 1, 2023 and as Chief Financial Officer at Jounce Therapeutics, Inc. from August 2015, where she also held the position of Treasurer since February 2013 and served as its Principal Accounting Officer. She has been a Independent Non-Executive Director at Imugene Limited since June 21, 2023 and served as an Independent Director at Yumanity Therapeutics, Inc. from December 22, 2020, to December 2022 and at Proteostasis Therapeutics, Inc. from February 2019 through December 2020. Ms. Drapkin is independent in accordance with the applicable rules of the Nasdaq Stock Market LLC and serves Independent Director of Acumen Pharmaceuticals, Inc. since March 2022. From 2009 to August 2015, she was the owner of KCD Financial LLC, through which she served as Jounce Therapeutics’ Interim Chief Financial Officer from 2012 to August 2015 and consulted for numerous biotechnology companies. She has also served as Chief Financial Officer of DeuteRx, LLC and EPIX Pharmaceuticals, Inc. from August 16, 2006, to July 2009, where she was also the Principal Accounting Officer until July 2009. Ms. Drapkin has extensive experience in building and leading finance functions, raising capital and leading strategic financial planning. She served as Chief Financial Officer of Predix Pharmaceuticals, Inc. since March 2, 2002 and was a Director of Kineta, Inc. until December 2022 and served as its Independent Director since June 2023 until June 30, 2025. She was also a Member of the Board of Directors of Proteostasis since February 2019 and held senior positions, including Director of Finance at Millennium Pharmaceuticals, Inc., with leadership responsibility for financial reporting, technical accounting, Sarbanes-Oxley compliance and internal audit from 1995 to February 2005. She previously served on the board of directors of Proteostatis Therapeutics, Inc. from February 2019 through December 2020. Earlier in her career, she served as an Auditor in the technology and life sciences audit practice at PricewaterhouseCoopers LLP, Boston, leading technical accounting, external financial reporting and internal audit functions and served as project leader for its Sarbanes-Oxley implementation program. She previously served on the board of directors of Kineta, Inc. from June 2023 to June 2025. Ms. Drapkin is a graduate of Babson College, holding a B.S. in Accounting and is a Certified Public Accountant.
Positions
- Company NameClimb Bio, Inc.Stock CodeCLYMPositionIndependent DirectorColleagues
- AMAoife M. BrennanCEO, President & Director
- DEDouglas Edward WilliamsIndependent Chairman of the Board
- SASusan AltschullerCFO & Principal Accounting Officer
- PWPerrin WilsonChief Business Officer
- AVAdam VillaSenior Vice President of Technical Operations
- CAChandra AdamsSenior VP, General Counsel & Secretary
- AGAlexander G. CumboIndependent Director
- KCKimberlee Cobleigh DrapkinIndependent Director
- JAJudith A. DunnIndependent Director
- Company NameAcumen Pharmaceuticals, Inc.Stock CodeABOSPositionIndependent DirectorColleagues
- DJDaniel J. O'ConnellCEO & Director
- GSGeorge S. GolumbeskiIndependent Chairman of the Board
- JDJames DohertyPresident & Chief Development Officer
- MZMatt ZugaCFO & Chief Business Officer
- GAGrant A. KrafftCo-Founder
- CECaleb E. FinchCo-Founder
- JLJeffrey L. C. IvesIndependent Director
- LSLaura StoppelIndependent Director
